252 related articles for article (PubMed ID: 28233900)
41. Value of FDG PET in the assessment of patients with multiple myeloma.
Bredella MA; Steinbach L; Caputo G; Segall G; Hawkins R
AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
[TBL] [Abstract][Full Text] [Related]
42. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
Wolf MB; Murray F; Kilk K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Eur J Radiol; 2014 Jul; 83(7):1222-1230. PubMed ID: 24793843
[TBL] [Abstract][Full Text] [Related]
43. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography.
Mahnken AH; Wildberger JE; Gehbauer G; Schmitz-Rode T; Blaum M; Fabry U; Günther RW
AJR Am J Roentgenol; 2002 Jun; 178(6):1429-36. PubMed ID: 12034612
[TBL] [Abstract][Full Text] [Related]
44. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.
Kröpil P; Fenk R; Fritz LB; Blondin D; Kobbe G; Mödder U; Cohnen M
Eur Radiol; 2008 Jan; 18(1):51-8. PubMed ID: 17924119
[TBL] [Abstract][Full Text] [Related]
45. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
[TBL] [Abstract][Full Text] [Related]
46. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
[TBL] [Abstract][Full Text] [Related]
47. Rectal cancer staging: Multidetector-row computed tomography diagnostic accuracy in assessment of mesorectal fascia invasion.
Ippolito D; Drago SG; Franzesi CT; Fior D; Sironi S
World J Gastroenterol; 2016 May; 22(20):4891-900. PubMed ID: 27239115
[TBL] [Abstract][Full Text] [Related]
48. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.
Rahmouni A; Divine M; Mathieu D; Golli M; Dao TH; Jazaerli N; Anglade MC; Reyes F; Vasile N
AJR Am J Roentgenol; 1993 May; 160(5):1049-52. PubMed ID: 8470574
[TBL] [Abstract][Full Text] [Related]
49. Whole Body Low Dose Computed Tomography (WBLDCT) Can Be Comparable to Whole-Body Magnetic Resonance Imaging (WBMRI) in the Assessment of Multiple Myeloma.
Ippolito D; Giandola T; Maino C; Gandola D; Ragusi M; Bonaffini PA; Sironi S
Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34064594
[TBL] [Abstract][Full Text] [Related]
50. A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions.
Nayak NB; Salah R; Huang JC; Hathout GM
Acta Neurol Scand; 2014 Mar; 129(3):198-203. PubMed ID: 23980614
[TBL] [Abstract][Full Text] [Related]
51. Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
Nanni C; Zamagni E; Versari A; Chauvie S; Bianchi A; Rensi M; Bellò M; Rambaldi I; Gallamini A; Patriarca F; Gay F; Gamberi B; Cavo M; Fanti S
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):414-21. PubMed ID: 26475305
[TBL] [Abstract][Full Text] [Related]
52. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
[TBL] [Abstract][Full Text] [Related]
53. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
Dutoit JC; Verstraete KL
Skeletal Radiol; 2017 Jun; 46(6):733-750. PubMed ID: 28289855
[TBL] [Abstract][Full Text] [Related]
54. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
55. Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma.
Prieto E; García-Velloso MJ; Aquerreta JD; Rosales JJ; Bastidas JF; Soriano I; Irazola L; Rodríguez-Otero P; Quincoces G; Martí-Climent JM
Phys Med; 2021 Apr; 84():1-9. PubMed ID: 33799056
[TBL] [Abstract][Full Text] [Related]
56. Differentiating diffuse from focal pattern on Computed Tomography in multiple myeloma: Added value of a Radiomics approach.
Tagliafico AS; Cea M; Rossi F; Valdora F; Bignotti B; Succio G; Gualco S; Conte A; Dominietto A
Eur J Radiol; 2019 Dec; 121():108739. PubMed ID: 31733431
[TBL] [Abstract][Full Text] [Related]
57. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
58. Improved Follow-Up and Response Monitoring of Thoracic Cage Involvement in Multiple Myeloma Using a Novel CT Postprocessing Software: The Lessons We Learned.
Bier G; Mustafa DF; Kloth C; Weisel K; Ditt H; Nikolaou K; Horger M
AJR Am J Roentgenol; 2016 Jan; 206(1):57-63. PubMed ID: 26700335
[TBL] [Abstract][Full Text] [Related]
59. Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria.
Ormond Filho AG; Carneiro BC; Pastore D; Silva IP; Yamashita SR; Consolo FD; Hungria VTM; Sandes AF; Rizzatti EG; Nico MAC
Radiographics; 2019; 39(4):1077-1097. PubMed ID: 31283452
[TBL] [Abstract][Full Text] [Related]
60. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
